Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-11-032007
Filing Date
2011-06-08
Accepted
2011-06-08 17:29:36
Documents
2
Period of Report
2011-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 10188
2 POWER OF ATTORNEY poa1.htm EX-24 5005
  Complete submission text file 0001140361-11-032007.txt   16838
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

EIN.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address
DAVE KAUSHIK J (Reporting) CIK: 0001522751 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32302 | Film No.: 11901681